343 reports of this reaction
3.5% of all VONOPRAZAN FUMARATE reports
#4 most reported adverse reaction
NAUSEA is the #4 most commonly reported adverse reaction for VONOPRAZAN FUMARATE. There are 343 FDA adverse event reports linking VONOPRAZAN FUMARATE to NAUSEA. This represents approximately 3.5% of all 9,763 adverse event reports for this drug.
Patients taking VONOPRAZAN FUMARATE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among VONOPRAZAN FUMARATE users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for VONOPRAZAN FUMARATE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 343 FDA reports for VONOPRAZAN FUMARATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.5% of all adverse event reports for VONOPRAZAN FUMARATE, making it a notable side effect.
If you experience nausea while taking VONOPRAZAN FUMARATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.